000756 新华制药
已收盘 09-04 15:00:00
资讯
新帖
简况
股市必读：新华制药新发布《关于阿奇霉素片通过仿制药一致性评价的公告》
证券之星 · 09-02
股市必读：新华制药新发布《关于阿奇霉素片通过仿制药一致性评价的公告》
新华制药：阿奇霉素片通过仿制药一致性评价
南方财经网 · 08-31
新华制药：阿奇霉素片通过仿制药一致性评价
新华制药最新公告：获得盐酸达泊西汀片药品注册证书
证券之星 · 08-28
新华制药最新公告：获得盐酸达泊西汀片药品注册证书
康方生物依沃西联合化疗一线治疗胆道癌Ⅲ期达到OS主要终点；新华制药2026年上半年净利润同比下降33.35%
同花顺 · 08-27
康方生物依沃西联合化疗一线治疗胆道癌Ⅲ期达到OS主要终点；新华制药2026年上半年净利润同比下降33.35%
新华制药（000756）2026年中报简析：净利润同比下降33.35%
证券之星 · 08-27
新华制药（000756）2026年中报简析：净利润同比下降33.35%
图解新华制药中报：第二季度单季净利润同比下降41.59%
证券之星 · 08-26
图解新华制药中报：第二季度单季净利润同比下降41.59%
新华制药（000756）披露2026年半年度报告，8月25日股价上涨2.66%
证券之星 · 08-25
新华制药（000756）披露2026年半年度报告，8月25日股价上涨2.66%
新华制药：上半年归母净利润同比降33.4%至1.49亿元
财中社 · 08-25
新华制药：上半年归母净利润同比降33.4%至1.49亿元
股市必读：新华制药新发布《关于获得达格列净片药品注册证书的公告》
证券之星 · 08-24
股市必读：新华制药新发布《关于获得达格列净片药品注册证书的公告》
新华制药：达格列净片获药品注册证书
财中社 · 08-21
新华制药：达格列净片获药品注册证书
新华制药达格列净片获国家药监局药品注册证书
美股速递 · 08-21
新华制药达格列净片获国家药监局药品注册证书
新华制药：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组
证券之星 · 08-10
新华制药：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组
新华制药（000756）披露2025年度A股派息实施公告，7月22日股价上涨0.07%
证券之星 · 07-22
新华制药（000756）披露2025年度A股派息实施公告，7月22日股价上涨0.07%
新华制药：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组
证券之星 · 07-08
新华制药：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组
6月29日新华制药（000756）涨停分析：新药获批、一致性评价驱动
证券之星 · 06-29
6月29日新华制药（000756）涨停分析：新药获批、一致性评价驱动
异动快报：新华制药（000756）6月29日10点9分触及涨停板
证券之星 · 06-29
异动快报：新华制药（000756）6月29日10点9分触及涨停板
新华制药（000756）披露2025年周年股东会决议公告，6月26日股价下跌8.18%
证券之星 · 06-26
新华制药（000756）披露2025年周年股东会决议公告，6月26日股价下跌8.18%
股市必读：新华制药6月23日涨停收盘，收盘价13.44元
证券之星 · 06-24
股市必读：新华制药6月23日涨停收盘，收盘价13.44元
亚太市场遭遇“黑色星期二” 恒科跌超3%，MiniMax跌超16%，超百亿港元资金抄底！
每日经济新闻 · 06-23
亚太市场遭遇“黑色星期二” 恒科跌超3%，MiniMax跌超16%，超百亿港元资金抄底！
创新药板块盘初冲高，海南海药、新华制药涨停
每日经济新闻 · 06-23
创新药板块盘初冲高，海南海药、新华制药涨停
加载更多
公司概况
公司名称：
山东新华制药股份有限公司
所属行业：
医药制造业
上市日期：
1997-08-06
主营业务：
山东新华制药股份有限公司的主营业务是开发、制造和销售化学原料药、制剂及化工产品。公司的主要产品是“新华牌”解热镇痛类药物、心脑血管类、抗感染类、中枢神经类。
发行价格：
3.45
{"stockData":{"symbol":"000756","market":"SZ","secType":"STK","nameCN":"新华制药","latestPrice":13.18,"timestamp":1788505386000,"preClose":13.22,"halted":0,"volume":4398473,"delay":0,"changeRate":-0.003,"floatShares":499000000,"shares":697000000,"eps":0.309,"marketStatus":"已收盘","change":-0.04,"latestTime":"09-04 15:00:00","open":13.26,"high":13.36,"low":13.13,"amount":58311000,"amplitude":0.0174,"askPrice":13.19,"askSize":24,"bidPrice":13.18,"bidSize":171,"shortable":0,"etf":0,"ttmEps":0.309,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":5,"adr":0,"adjPreClose":13.22,"symbolType":"stock","openAndCloseTimeList":[[1788485400000,1788492600000],[1788498000000,1788505200000]],"highLimit":14.54,"lowLimit":11.9,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":696683435,"isCdr":false,"pbRate":1.75,"roa":"--","peRate":42.653722,"roe":"2.81%","epsLYR":0.42,"committee":0.618395,"marketValue":9182000000,"turnoverRate":0.0088,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-07。","hkstockBrief":{"symbol":"00719","market":"HK","secType":"STK","nameCN":"山东新华制药股份","latestPrice":5.65,"timestamp":1788509281743,"preClose":5.62,"halted":0,"volume":76000,"delay":0,"premium":"-63.32"},"floatMarketCap":6575000000},"requestUrl":"/m/hq/s/000756","defaultTab":"news","newsList":[{"id":"2664863910","title":"股市必读：新华制药新发布《关于阿奇霉素片通过仿制药一致性评价的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664863910","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664863910?lang=zh_cn&edition=full","pubTime":"2026-09-02 01:36","pubTimestamp":1788284173,"startTime":"0","endTime":"0","summary":"公司公告汇总：全资子公司阿奇霉素片通过仿制药一致性评价，该产品为医保甲类品种，2025年公立医疗机构销售额约6.7亿元。公司公告汇总关于阿奇霉素片通过仿制药一致性评价的公告山东新华制药股份有限公司全资子公司山东淄博新达制药有限公司收到国家药品监督管理局核准签发的阿奇霉素片《药品补充申请批准通知书》，该产品通过仿制药质量和疗效一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200001957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076882","title":"新华制药：阿奇霉素片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076882","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663076882?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:51","pubTimestamp":1788166260,"startTime":"0","endTime":"0","summary":"南财智讯8月31日电，新华制药公告，其全资子公司山东淄博新达制药有限公司收到国家药监局核准签发的《药品补充申请批准通知书》，阿奇霉素片通过仿制药质量和疗效一致性评价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860136938.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860136938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662996065","title":"新华制药最新公告：获得盐酸达泊西汀片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2662996065","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662996065?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:32","pubTimestamp":1787909555,"startTime":"0","endTime":"0","summary":"新华制药(000756.SZ)公告称，公司收到国家药监局核准签发的盐酸达泊西汀片《药品注册证书》，该药品适用于治疗18至64岁男性早泄患者。2025年中国公立医疗机构达泊西汀销售额约10.3亿元。此次获批将进一步丰富公司制剂产品线，提升市场竞争力。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800040086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662728077","title":"康方生物依沃西联合化疗一线治疗胆道癌Ⅲ期达到OS主要终点；新华制药2026年上半年净利润同比下降33.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662728077","media":"同花顺","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662728077?lang=zh_cn&edition=full","pubTime":"2026-08-27 07:01","pubTimestamp":1787785260,"startTime":"0","endTime":"0","summary":"丨2026年8月27日星期四丨 NO.1康方生物依沃西联合化疗一线治疗胆道癌Ⅲ期达到OS主要终点8月26日晚间，康方生物宣布，公司全球首创的肿瘤免疫2.0基石药物依沃西联合化疗方案，对比度伐利尤单 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260827/c679322298.shtml","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260827/c679322298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662402417","title":"新华制药（000756）2026年中报简析：净利润同比下降33.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662402417","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662402417?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:22","pubTimestamp":1787782975,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期新华制药发布2026年中报。根据财报显示，新华制药净利润同比下降33.35%。截至本报告期末，公司营业总收入43.58亿元，同比下降6.06%，归母净利润1.49亿元，同比下降33.35%。按单季度数据看，第二季度营业总收入19.34亿元，同比下降12.43%，第二季度归母净利润6522.45万元，同比下降41.59%。去年的净利率为3.5%，算上全部成本后，公司产品或服务的附加值不高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700011550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662751827","title":"图解新华制药中报：第二季度单季净利润同比下降41.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662751827","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662751827?lang=zh_cn&edition=full","pubTime":"2026-08-26 02:15","pubTimestamp":1787681725,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药2026年中报显示，上半年度公司主营收入43.58亿元，同比下降6.06%；归母净利润1.49亿元，同比下降33.35%；扣非净利润1.47亿元，同比下降30.14%；其中2026年第二季度，公司单季度主营收入19.34亿元，同比下降12.43%；单季度归母净利润6522.45万元，同比下降41.59%；单季度扣非净利润6701.79万元，同比下降36.68%；负债率39.32%，投资收益736.31万元，财务费用3049.52万元，毛利率19.16%。财报数据概要请见下图:本文数据来源于新华制药2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600005041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758039","title":"新华制药（000756）披露2026年半年度报告，8月25日股价上涨2.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662758039?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:24","pubTimestamp":1787667869,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，新华制药报收于13.52元，较前一交易日上涨2.66%，最新总市值为94.19亿元。该股当日开盘13.05元，最高13.57元，最低12.99元，成交额达1.44亿元，换手率为2.16%。近日，新华制药发布2026年半年度报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500050802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735568","title":"新华制药：上半年归母净利润同比降33.4%至1.49亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735568","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662735568?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:54","pubTimestamp":1787651640,"startTime":"0","endTime":"0","summary":"8月25日，新华制药(000756)公布2026年半年报，公司营业收入为43.6亿元，同比下降6.1%；归母净利润为1.49亿元，同比下降33.4%；扣非归母净利润为1.47亿元，同比下降30.1%；经营现金流净额为1.61亿元，同比下降31.4%；EPS(全面摊薄)为0.2141元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608253852995256.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608253852995256.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661243007","title":"股市必读：新华制药新发布《关于获得达格列净片药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2661243007","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661243007?lang=zh_cn&edition=full","pubTime":"2026-08-24 01:33","pubTimestamp":1787506390,"startTime":"0","endTime":"0","summary":"公司公告汇总关于获得达格列净片药品注册证书的公告山东新华制药股份有限公司近日收到国家药品监督管理局核准签发的达格列净片《药品注册证书》，药品注册分类为化学药品4类，适用于2型糖尿病和心力衰竭成人患者。2025年中国公立医疗机构达格列净片销售额约为114亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400000924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661610392","title":"新华制药：达格列净片获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2661610392","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661610392?lang=zh_cn&edition=full","pubTime":"2026-08-21 18:05","pubTimestamp":1787306700,"startTime":"0","endTime":"0","summary":"8月21日，新华制药（000756/00719）发布公告，近日，公司收到国家药品监督管理局签发的达格列净片《药品注册证书》。该药品为处方药，剂型为片剂，规格包括10mg和5mg，注册分类为化学药品4类。达格列净片适用于2型糖尿病成人患者，可作为单药治疗或与其他药物联合使用改善血糖控制。此外，本品还适用于心力衰竭成人患者，降低相关风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608213849412573.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608213849412573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120448483","title":"新华制药达格列净片获国家药监局药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=1120448483","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120448483?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:44","pubTimestamp":1787301877,"startTime":"0","endTime":"0","summary":"新华制药（000756）近日宣布，其达格列净片的药品注册证书已正式获得国家药品监督管理局的批准并予以颁发。这一关键进展标志着该产品在监管审批层面取得了实质性突破，为公司进一步拓展糖尿病治疗领域的市场版图奠定了坚实基础。达格列净作为一种广泛应用于临床的SGLT2抑制剂类药物，其获批不仅丰富了新华制药的产品线，也彰显了公司在仿制药研发与注册申报方面的综合实力。此次证书的落地，意味着该药品即将进入商业化生产的快车道，有望为患者提供更多优质、可及的治疗选择，同时对公司未来的业绩增长构成积极利好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658989062","title":"新华制药：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2658989062","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658989062?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:42","pubTimestamp":1786351326,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药08月10日在投资者关系平台上答复投资者关心的问题。公司于2025年 6月20 日在巨潮资讯网公告了《关于 OAB-14 干混悬剂完成Ⅱ期临床中国首例患者入组的公告》，Ⅱ期临床试验正按计划推进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000020678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653676526","title":"新华制药（000756）披露2025年度A股派息实施公告，7月22日股价上涨0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653676526","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653676526?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:12","pubTimestamp":1784729540,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，新华制药报收于13.48元，较前一交易日上涨0.07%，最新总市值为93.91亿元。近日，新华制药发布2025年度A股派息实施公告。公告显示，公司2025年度A股派息方案已获2026年6月26日召开的年度股东会审议通过，以现有A股股本501,683,435股为基数，向全体A股股东每10股派发现金红利1.50元（含税）。H股股东权益分派不适用本公告。本次派息方案实施后，公司将按规定调整股票期权激励计划行权价格。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200047278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","399300","BK0239","159982","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649682956","title":"新华制药：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2649682956","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649682956?lang=zh_cn&edition=full","pubTime":"2026-07-08 08:39","pubTimestamp":1783471153,"startTime":"0","endTime":"0","summary":"投资者提问：董秘你好，贵公司新华制药的阿尔茨海默病新药OAB-14已进入I期临床试验，受试者入组基本完成，具备清除AB淀粉样蛋白等多靶点特性，是当前全球首个靶向AB清除的多靶点小分子抗AD药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800008255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647632941","title":"6月29日新华制药（000756）涨停分析：新药获批、一致性评价驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2647632941","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647632941?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:33","pubTimestamp":1782718432,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药6月29日涨停收盘，收盘价13.59元。6月29日新华制药涨停的可能因素有：公司于6月27日公告获批盐酸莫西沙星氯化钠注射液药品注册证书，属抗感染领域重磅仿制药；同期披露布洛芬混悬液通过一致性评价，强化OTC与处方药双线布局；叠加近期医药板块政策面回暖，国家医保谈判节奏预期调整及集采温和化信号增强，市场对公司存量品种放量及新批文落地预期提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900017400.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647342499","title":"异动快报：新华制药（000756）6月29日10点9分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2647342499","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647342499?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:10","pubTimestamp":1782699051,"startTime":"0","endTime":"0","summary":"证券之星6月29日盘中消息，10点9分新华制药（000756）触及涨停板。其所属行业化学制药目前上涨。领涨股为广生堂。该股为阿尔茨海默病，创新药，合成生物概念热股，当日阿尔茨海默病概念上涨2.38%，创新药概念上涨1.88%，合成生物概念上涨1.66%。6月26日的资金流向数据方面，主力资金净流出1940.84万元，占总成交额5.8%，游资资金净流出269.93万元，占总成交额0.81%，散户资金净流入2210.77万元，占总成交额6.6%。近5日资金流向一览见下表：新华制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900007610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646365872","title":"新华制药（000756）披露2025年周年股东会决议公告，6月26日股价下跌8.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646365872","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646365872?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:27","pubTimestamp":1782484040,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，新华制药报收于12.35元，较前一交易日下跌8.18%，最新总市值为86.04亿元。该股当日开盘13.35元，最高13.76元，最低12.35元，成交额达3.35亿元，换手率为5.19%。近日，山东新华制药股份有限公司发布2025年周年股东会决议公告。会议还审议通过了续聘致同会计师事务所为2026年度审计机构、2026年度董事薪酬方案及董事高管薪酬管理制度等议案。现场及网络投票股东共336人，代表有表决权股份总数33.48%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600045680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645858028","title":"股市必读：新华制药6月23日涨停收盘，收盘价13.44元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645858028","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645858028?lang=zh_cn&edition=full","pubTime":"2026-06-24 00:57","pubTimestamp":1782233832,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘，新华制药报收于13.44元，上涨9.98%，涨停，换手率2.13%，成交量10.61万手，成交额1.41亿元。交易信息汇总股价提醒新华制药6月23日涨停收盘，收盘价13.44元；该股于9点32分涨停，盘中1次打开涨停；截至收盘，封单资金为7412.49万元，占其流通市值1.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400000872.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645431882","title":"亚太市场遭遇“黑色星期二” 恒科跌超3%，MiniMax跌超16%，超百亿港元资金抄底！","url":"https://stock-news.laohu8.com/highlight/detail?id=2645431882","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645431882?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:36","pubTimestamp":1782207374,"startTime":"0","endTime":"0","summary":"今日（6月23日），亚太市场遭遇“黑色星期二”，各市场主要股指全线下挫，港股市场自然难以独善其身。截至收盘，恒生指数报23336.28点，下跌432.24点，跌幅1.82%。恒生科技指数报4399.22点，下跌150.19点，跌幅3.30%。周边市场方面，日经225指数大跌3.55%，韩国KOSPI指数跌近10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606233779798183.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606233779798183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HSI","BK1191","02800","03037","03032","83115","03088","BK0155","03423","BK1515","MHImain","MCHmain","BK0201","03033","09115","02837","300568","02833","00719","09067","06067","000756","03067","09088","03115","07200","03419","HHImain","03417","07500","HSTECH","07226","BK0229","07300","513600","82800","07552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645300158","title":"创新药板块盘初冲高，海南海药、新华制药涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2645300158","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645300158?lang=zh_cn&edition=full","pubTime":"2026-06-23 09:36","pubTimestamp":1782178606,"startTime":"0","endTime":"0","summary":"6月23日，创新药板块盘初冲高，海南海药、新华制药涨停，粤万年青、华森制药、长春高新、小方制药、通化东宝跟涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606233779039790.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606233779039790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","BK0146","BK0060","BK0070","000756","BK1574","BK0188","000566","BK0239","BK1161","BK0164","159992"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788595545667,"stockEarnings":[{"period":"1week","weight":-0.0186},{"period":"1month","weight":-0.0358},{"period":"3month","weight":0.0436},{"period":"6month","weight":-0.1335},{"period":"1year","weight":-0.1722},{"period":"ytd","weight":-0.1351}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0133},{"period":"3month","weight":-0.0242},{"period":"6month","weight":-0.0471},{"period":"1year","weight":0.0436},{"period":"ytd","weight":-0.0098}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东新华制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"79848人(较上一季度增加Infinity%)","perCapita":"6247股","listingDate":"1997-08-06","address":"山东省淄博市张店区高新区鲁泰大道1号","registeredCapital":"69668万元","survey":" 山东新华制药股份有限公司的主营业务是开发、制造和销售化学原料药、制剂及化工产品。公司的主要产品是“新华牌”解热镇痛类药物、心脑血管类、抗感染类、中枢神经类。","listedPrice":3.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新华制药,000756,新华制药股票,新华制药股票老虎,新华制药股票老虎国际,新华制药行情,新华制药股票行情,新华制药股价,新华制药股市,新华制药股票价格,新华制药股票交易,新华制药股票购买,新华制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}